raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:275798

Pulmonary arterial hypertension associated with connective tissue disease

Synonyms: PAH associated with connective tissue disease

Type
Clinical group
Group
Group of disorders
Inheritance
Not applicable
Age of onset
All ages
Status
active

A form of pulmonary arterial hypertension (PAH) characterized by an elevated pulmonary arterial resistance leading to right heart failure observed as a complication of a connective tissue disease.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enPulmonary arterial hypertension associated with connective tissue diseasePAH associated with connective tissue disease
frHypertension artérielle pulmonaire associée à une connectiviteHTAP associée à une connectivite
dePulmonale arterielle Hypertonie mit assoziierter BindegewebskrankheitPAH mit assoziierter Bindegewebskrankheit
esHipertensión arterial pulmonar asociada a enfermedad del tejido conectivoHAP asociada a enfermedad del tejido conectivo
itIpertensione arteriosa polmonare associata a malattia del tessuto connettivoPAH associata a malattia del tessuto connettivo
nlPulmonale arteriële hypertensie geassocieerd met bindweefselziektePAH geassocieerd met bindweefselziekte
ptHipertensão arterial pulmonar associada a doença do tecido conjuntivo
plTętnicze nadciśnienie płucne związane z chorobą tkanki łącznejPAH związane z chorobą tkanki łącznej
csPlicní arteriální hypertenze asociovaná s nemocí pojivaPAH asociovaná s nemocí pojiva
ukЛегенева артеріальна гіпертензія, асоційована із захворюванням сполучної тканиниЛАГ, повязана із захворюваннями сполучної тканини
zh结缔组织病相关肺动脉高压结缔组织病相关PAH
trBağ dokusu hastalığı ilişkili pulmoner arteriyel hipertansiyonBağ dokusu hastalığı ile ilişkili PAH

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
MONDO17151Evalidated
UMLSC3697982Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
HLA-BMajor susceptibility factor inNot yet assessedHGNC:4932ENSG000002347451428306p21.33major histocompatibility complex, class I, B
5

Prevalence and incidence

8 records
TypeClassValueAreaQualificationValidationSource
Point prevalence1-9 / 1 000 0000.23 / 100 000FranceValue and classValidated16456139[PMID]
Annual incidence<1 / 1 000 0000.036 / 100 000FranceValue and classValidated16456139[PMID]
Point prevalence1-9 / 1 000 0000.25 / 100 000SpainValue and classValidated22362843[PMID]
Point prevalence1-9 / 100 0001.25 / 100 000United KingdomValue and classValidated21885399[PMID]_17360728[PMID]
Annual incidence1-9 / 1 000 0000.25 / 100 000United KingdomValue and classValidated21885399[PMID]_17360728[PMID]
Point prevalence1-9 / 1 000 0000.25 / 100 000Czech RepublicValue and classValidated24629043[PMID]
Annual incidence1-9 / 1 000 0000.12 / 100 000Czech RepublicValue and classValidated24629043[PMID]
Point prevalence1-9 / 1 000 0000.25 / 100 000EuropeValue and classValidated24629043[PMID]_22362843[PMID]_16456139[PMID]_21885399[PMID]_17360728[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card